advertisement

Leg Vein Health

08 April 2011

Restless legs syndrome drug approved

US regulators have approved XenoPort Inc's drug Horizant to treat restless legs syndrome (RLS).

US regulators have approved XenoPort Inc's drug Horizant to treat restless legs syndrome (RLS).

The FDA has asked the company to conduct a number of post-marketing studies, focusing mainly on the potential for driving impairment.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.